DIABETES MELLITUS PART 2 Flashcards

1
Q
sudden onset
polyuria
25% present with DKA
weight loss
 blurred vision
paresthesias
A

type I DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

gradual onset of hyperglycemia
metabolic signs often realized in retrospect
GU signs: balanitis, candidly vulvovaginitis

A

type 2 DM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what percent of dosing should be basal insulin?

A

40-50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

NPH, Detemir, Glargine are examples of what kind of insulin?

what about Degludec?

A

basal insulin, intermediate to long acting preparation

basal insulin, very long acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

this is the preferred initial agent in asymptomatic patients without catabolism

if A1C is greater 7.5-8% then medication should be considered?

side effects: GI, Vit B12 deficiency, reduced lactate uptake by liver

A

metformin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what conditions should you worry about lactic acidosis with the use of metformin?

renal failure
liver failure
excess alcohol intake
all the above

A

all the above

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the goal Hgb A1C for most patients being for treated diabetes is?

<6
<6.5
<7
<7.5
<8
A

goal Hgb A1C <7.0%

FBG 80-130 mg/dL
PP glucose (90-120 min) <180 mg/dL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

of the parameters listed, which is least important in the CV health of an elderly patient?

cholesterol
blood pressure
fasting blood sugar

A

blood sugar

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

when considering secondary medication following metformin in a diabetic patient with continued elevation of Hgb A1C level and established CV disease, which agent is preferred?

GLP-1 RA
Glyburide
SGLT-2 inhibitor
insulin

A

GLP-1 RA

reduces incidence of:
nonfatal MI
nonfatal stroke
death from CV causes

and

slow the rate of decline in GFR and worsening of albuminuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

when considering secondary medication following metformin in a diabetic patient with continued elevation of Hgb A1C level and heart failure, which agent is preferred?

GLP-1RA
Glyburide
SGLT-2 inhibitor
insulin

A

SGLT-2 inhibitor

empagliflozin and canagliflozin lower CV death (MI, stroke)

dapagliflozin lowers risk of HF or CV death

if HF or CKD, SGLT2 inhibitors slow the rate of decline of GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

common side effect of SGLT-2 inhibitors is?

thrombocytopenia
GU yeast infections
Rash
anaphylaxis

A

GU yeast infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

when considering secondary medication following metformin in a diabetic patient with fasting BG?250 mg/dL, Hgb A1C level >9.0% and ketonuria, which agent is preferred?

GLP-1RA
glyburide
SGLT-2 inhibitor
insulin

A

insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

which meds for diabetes can causes weight gain?

insulin and sulfonylureas
GLP-1 RAs and DPP-4 inhibitors
SGLT-2 inhibitors
metformin

A

insulin and sulfonylureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

of the medications listed below, which is considered first line for tx for HFrEF?

empagliflozin
sacubitril/valsartan
lisinopril
epleronone

A

sacubitril/valsartan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what SGLT-2 inhibitor has been added to the list of recommended agents in HFrEF?

A

empagliflozin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

previously, no medications were shown to have an outcome improvement in HFpEF. What meds have now been shown to have an outcome improvement?

lisinopril
sacubitril/valsartan
empagliflozin
epleronone

A

sacubitril/valsartan

17
Q

when monitoring heart rhythm with implantable or surface devices, what percentage or patients have >5 minutes of asymptomatic atrial fibrillation?

<10%
35%
50%
70%

A

35%

18
Q

what is worse of the oxygen supply demand mismatch of the heart?

tachycardia
hypertension

A

tachycardia

19
Q

what is the normal contribution of atrial contraction to total ventricular filling of blood?

10-15%
20-25%
45-50%
100%

A

20-25%

20
Q

what area of the heart is a clot likely to form during episodes of blood stagnation due to atrial fibrillation and leads to a stroke?

right atrium
right ventricle
left atrium
left ventricle

A

left atrium

21
Q

the most frequent manifestation of embolization in patients with atrial fibrillation is?

renal infarct
coronary artery embolus
acute ischemic stroke
mesenteric ischemia

A

acute ischemic stroke

22
Q

of the tests listed, which test should be ordered in a patient with a new diagnosis of atrial fibrillation:

procalcitonin
TSH, FT4
cortisol level
epinephrine level

A

TSH, FT4

23
Q

A 68 y/p patient with a history of HTN presents to the ED with new onset of palpitations and AF (rate 120) on ECG. His is otherwise asymptomatic and stable. What would be a reasonable first intervention for this patient?

metoprolol
amiodorone
electrical cardioversion

A

metoprolol